[1] |
刘祖国,王华. 关注干眼慢性疾病管理体系的建设[J]. 中华眼科杂志,2018, 54(2):81-83.
|
[2] |
Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes[J]. CLAO J, 1995, 21(4):221-232.
|
[3] |
Lemp MA. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)[J]. Ocul Surf, 2007, 5(2):75-92.
|
[4] |
Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWSⅡ Definition and Classification Report[J]. Ocul Surf, 2017, 15(3):276-283.
|
[5] |
Yokoi N, Bron AJ, Georgiev GA. The Precorneal Tear Film as a Fluid Shell: The Effect of Blinking and Saccades on Tear Film Distribution and Dynamics[J]. Ocul Surf, 2014, 12(4):252-266.
|
[6] |
King-Smith PE, Fink BA, Nichols JJ, et al. The Contribution of Lipid Layer Movement to Tear Film Thinning and Breakup[J]. Invest Ophthalmol Vis Sci, 2009, 50(6):2747-2756.
|
[7] |
Govindarajan B, Gipson IK. Membrane-tethered mucins have multiple functions on the ocular surface[J]. Exp Eye Res, 2010, 90(6):655-663.
|
[8] |
Zhou L, Zhao SZ, Koh SK, et al. In-depth analysis of the human tear proteome[J]. J Proteomics, 2012, 75(13):3877-3885.
|
[9] |
He JC, Bazan NG, Bazan HEP. Mapping the entire human corneal nerve architecture[J]. Exp Eye Res, 2010, 91(4):513-523.
|
[10] |
Hirata H, Rosenblatt MI. Hyperosmolar Tears Enhance Cooling Sensitivity of the Corneal Nerves in Rats: Possible Neural Basis for Cold-Induced Dry Eye Pain[J]. Invest Ophthalmol Vis Sci, 2014, 55(9):5821-5833.
|
[11] |
Guo B, Lu P, Chen XM, et al. Prevalence of dry eye disease in Mongolians at high altitude in China: the Henan eye study[J]. Ophthalmic Epidemiology, 2010, 17(4):234-241.
|
[12] |
Tong L, Tongg L, Saw SM, et al. A questionnaire-based assessment of symptoms associated with tear film dysfunction and lid margin disease in an Asian population[J]. Ophthalmic Epidemiology, 2009, 16(1):31-37.
|
[13] |
Uchino M, Schaumberg D, Dogru MY, et al. Prevalence of Dry Eye Disease among Japanese Visual Display Terminal Users[J]. Ophthalmology, 2008, 115(11):1982-1988.
|
[14] |
Tan LL, Morgan P, Cai ZQ, et al. Prevalence of and risk factors for symptomatic dry eye disease in Singapore[J]. Clinical & Experimental Optometry, 2015, 98(1):45-53.
|
[15] |
Viso E, Rodrã-Guez-Ares MT, Abelenda D, et al. Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain[J]. Invest Ophthalmol Vis Sci, 2012, 53(6):2601-2606.
|
[16] |
Liew M, Zhang M, Kim E, et al. Prevalence and predictors of Sjögren′s syndrome in a prospective cohort of patients with aqueous-deficient dry eye[J]. Bri J Ophthalmol, 2012, 96(12):1498-1503.
|
[17] |
Vehof J, Hysi PG, Hammond CJ. A Metabolome-Wide Study of Dry Eye Disease Reveals Serum Androgens as Biomarkers[J]. Ophthalmology, 2017, 124(4):505-511.
|
[18] |
Schaumberg DA, Buring JE, Sullivan DA, et al. Hormone replacement therapy and dry eye syndrome[J]. JAMA, 2001, 286(17):2114-2119.
|
[19] |
Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome[J]. Arch of Ophthalmol, 2000, 118(9):1264-1268.
|
[20] |
Sullivan DA, Rocha EM, Aragona P, et al. TFOS DEWS Ⅱ Sex, Gender, and Hormones Report[J]. Ocul Surf, 2017, 15(3):284-333.
|
[21] |
Eckstein AK, Finkenrath A, Heiligenhaus A, et al. Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies[J]. Acta Ophthalmologica, 2004, 82(3):291-297.
|
[22] |
Imbert Y, Foulks GN, Brennan MD, et al. MUC1 and estrogen receptor alpha gene polymorphisms in dry eye patients[J]. Exp Eye Res, 2009, 88(3):334-338.
|
[23] |
Suzuki T, Sullivan BD, Liu M, et al. Estrogen and progesterone effects on the morphology of the mouse meibomian gland[J]. Oxygen Transport to Tissue, 2000, 506(PtA):483-488.
|
[24] |
Zylberberg C, Seamon V, Ponomareva O, et al. Estrogen up-regulation of metalloproteinase-2 and -9 expression in rabbit lacrimal glands[J]. Exp Eye Res, 2007, 84(5):960-972.
|
[25] |
Seamon V, Vellala K, Zylberberg C, et al. Sex hormone regulation of tear lipocalin in the rabbit lacrimal gland[J]. Exp Eye Res, 2008, 87(3):184-190.
|
[26] |
Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome-A Delphi approach to treatment recommendations[J]. Cornea, 2006, 25(8):900-907.
|
[27] |
中华医学会眼科学分会角膜病学组. 干眼临床诊疗专家共识(2013年)[J]. 中华眼科杂志,2013, 49(1):73-75.
|
[28] |
Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWSⅡ Diagnostic Methodology report[J]. Ocul Surf, 2017, 15(3):539-574.
|
[29] |
Stern ME, Gao J, Siemasko KF, et al. The role of the lacrimal functional unit in the pathophysiology of dry eye[J]. Exp Eye Res, 2004, 78(3):409-416.
|
[30] |
Zhang X, M VJ, Qu Y, et al. Dry Eye Management: Targeting the Ocular Surface Microenvironment[J]. Int J Mol Sci, 2017, 18(7):1398.
|
[31] |
刘祖国. 干眼[M]. 北京:人民卫生出版社,2017: 82-93,42,98.
|
[32] |
Chalmers RL, Begley CG, Caffery B. Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): Discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses[J]. Cont Lens Anterior Eye, 2010, 33(2):55-60.
|
[33] |
Bandlitz S, Purslow C, Murphy PJ, et al. A new portable digital meniscometer[J]. Optom Vis Sci, 2014, 91(1):1-8.
|
[34] |
Tomlinson A, Bron AJ, Korb DR, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee[J]. Invest Ophthalmol Vis Sci, 2011, 52(4):2006-2049.
|
[35] |
袁进. 睑板腺功能的量化分析与评价[C].第一届全国眼表与泪液疾病学术大会暨第三届全国干眼学术会议汇编,长沙:2017.
|
[36] |
Sullivan BD, Crews LA, Messmer EM, et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications[J]. Acta Ophthalmol, 2014, 92(2):161-166.
|
[37] |
刘妍. 结膜印迹细胞学检查在干眼症诊断中的应用[J]. 国际眼科杂志,2010, 10(8):1574-1576.
|
[38] |
Sambursky R, Davitt WF, Latkany R, et al. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye[J]. JAMA Ophthalmol, 2013, 131(1):24-28.
|
[39] |
Liu R, Gao C, Chen H, et al. Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease[J]. PLoS One, 2017, 12(4):e0173301.
|
[40] |
Willcox MDP, Argueso P, Georgiev GA, et al. TFOS DEWSⅡ Tear Film Report[J]. Ocul Surf, 2017, 15(3):366-403.
|
[41] |
刘祖国. 干眼的临床诊断与治疗亟待规范化和精细化[J]. 中华眼科杂志,2017, 53(9):641-644.
|
[42] |
King-Smith PE, Reuter KS, Braun RJ, et al. Tear film breakup and structure studied by simultaneous video recording of fluorescence and tear film lipid layer images[J]. Invest Ophthalmol Vis Sci, 2013, 54(7):4900-4909.
|
[43] |
King-Smith PE, Hinel EA, Nichols JJ. Application of a novel interferometric method to investigate the relation between lipid layer thickness and tear film thinning[J]. Invest Ophthalmol Vis Sci, 2010, 51(5):2418-2423.
|
[44] |
Lam SM, Tong L, Reux B, et al. Lipidomic analysis of human tear fluid reveals structure-specific lipid alterations in dry eye syndrome[J]. J Lipid Res, 2014, 55(2):299-306.
|
[45] |
Govindarajan B, Gipson IK. Membrane-tethered mucins have multiple functions on the ocular surface[J]. Exp Eye Res, 2010, 90(6):655-663.
|
[46] |
Hodges RR, Dartt DA. Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins[J]. Exp Eye Res, 2013, 117(12):62-78.
|
[47] |
Millar TJ, Schuett BS. The real reason for having a meibomian lipid layer covering the outer surface of the tear film-A review[J]. Exp Eye Res, 2015, 137:125-138.
|
[48] |
Uchino Y, Mauris J, Woodward AM, et al. Alteration of Galectin-3 in Tears of Patients With Dry Eye Disease[J]. Am J Ophthalmol, 2015, 159(6):1027-1035.
|
[49] |
Sullivan BD, Whitmer D, Nichols KK, et al. An Objective Approach to Dry Eye Disease Severity[J]. Invest Ophthalmol Vis Sci, 2010, 51(12):6125-6130.
|
[50] |
Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report[J]. Ocul Surf, 2017, 15(3):438-510.
|
[51] |
Downie LE. Automated Tear Film Surface Quality Breakup Time as a Novel Clinical Marker for Tear Hyperosmolarity in Dry Eye Disease[J]. Invest Ophthalmol Vis Sci, 2015, 56(12):7260-7268.
|
[52] |
Liu HX, Begley C, Chen MH, et al. A Link between Tear Instability and Hyperosmolarity in Dry Eye[J]. Invest Ophthalmol Vis Sci, 2009, 50(8):3671-3679.
|
[53] |
Luo LH, Li DQ, Pflugfelder SC. Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways[J]. Cornea, 2007, 26(4):452-460.
|
[54] |
Gupta Y, Gupta M, Rizvi SAR, et al. Xerosis meter: a new concept in dry eye evaluation[J]. Graefes Arch Clin Exp Ophthalmol, 2006, 244(1):9-13.
|
[55] |
Gao Y, Min K, Zhang Y, et al. Female-Specific Downregulation of Tissue Polymorphonuclear Neutrophils Drives Impaired Regulatory T Cell and Amplified Effector T Cell Responses in Autoimmune Dry Eye Disease[J]. J Immunol, 2015, 195(7):3086-3099.
|
[56] |
Zhang X, Volpe EA, Gandhi NB, et al. NK cells promote Th-17 mediated corneal barrier disruption in dry eye[J]. PLoS One, 2012, 7(5):e36822.
|
[57] |
Chauhan SK, Dana R. Role of Th17 cells in the immunopathogenesis of dry eye disease[J]. Mucosal Immunol, 2009, 2(4):375-376.
|
[58] |
Kodati S, Chauhan SK, Chen YH, et al. CCR7 Is Critical for the Induction and Maintenance of Th17 Immunity in Dry Eye Disease [J]. Invest Ophthalmol Vis Sci, 2014, 55(9):5871-5877.
|
[59] |
Dohlman TH, Chauhan SK, Kodati S, et al. The CCR6/CCL20 Axis Mediates Th17 Cell Migration to the Ocular Surface in Dry Eye Disease[J]. Invest Ophthalmol Vis Sci, 2013, 54(6):4081-4091.
|
[60] |
高彩凤,陈慧瑾,靳瑛,等. Th17相关细胞因子在干眼患者眼表的表达及其相关性研究[J]. 中华实验眼科杂志,2014, 32(7):641-646.
|
[61] |
Belmonte C, Nichols JJ, Cox SM, et al. TFOS DEWS II pain and sensation report[J]. Ocul Surf, 2017, 15(3):404-437.
|
[62] |
Zhang X, Zhao L, Deng S, et al. Dry Eye Syndrome in Patients with Diabetes Mellitus: Prevalence, Etiology, and Clinical Characteristics[J]. J Ophthalmol, 2016, 2016(2):1-7.
|
[63] |
Labbe A, Liang Q, Wang Z, et al. Corneal nerve structure and function in patients with non-sjogren dry eye: clinical correlations[J]. Invest Ophthalmol Vis Sci, 2013, 54(8):5144-5150.
|
[64] |
Fernandes V, Sharma D, Vaidya S, et al. Cellular and molecular mechanisms driving neuropathic pain: recent advancements and challenges[J]. Expert Opin Ther Targets, 2018, 22(2):131-142.
|
[65] |
Stephen M. Wall and Melzack′s Text Book of Pain[M]. 6th ed. Berlin: Elsevier, 2013: 861-888.
|
[66] |
Bian F, Qi H, Ma P, et al. An immunoprotective privilege of corneal epithelial stem cells against Th17 inflammatory stress by producing glial cell-derived neurotrophic factor[J]. Stem Cells, 2010, 28(12):2172-2181.
|
[67] |
Green-Church KB, Butovich I, Willcox M, et al. The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Tear Film Lipids and Lipid-Protein Interactions in Health and Disease[J]. Invest Ophthalmol Vis Sci, 2011, 52(4):1979-1993.
|
[68] |
De MI, Gendron G, Miceli C, et al. Combination of the Schirmer I and phenol red thread tests as a rescue strategy for diagnosis of ocular dryness associated with Sjögren′s syndrome[J]. Invest Ophthalmol Vis Sci, 2011, 52(8):5167-5173.
|
[69] |
Lee SY, Han SJ, Nam SM, et al. Analysis of Tear Cytokines and Clinical Correlations in Sjogren Syndrome Dry Eye Patients and Non-Sjogren Syndrome Dry Eye Patients[J]. Am J Ophthalmol, 2013, 156(2):247-253.
|
[70] |
Corrales RM, Narayanan S, Fernandez I, et al. Ocular Mucin Gene Expression Levels as Biomarkers for the Diagnosis of Dry Eye Syndrome[J]. Invest Ophthalmol Vis Sci, 2011, 52(11):8363-8369.
|
[71] |
Willshire C, Buckley RJ, Bron AJ. Central Connections of the Lacrimal Functional Unit[J]. Cornea, 2017, 36(8):898-907.
|
[72] |
Welch D, Ousler GW, Nally LA, et al. Ocular drying associated with oral antihistamines (loratadine) in the normal population-an evaluation of exaggerated dose effect[J]. Adv Exp Med Biol, 2002, 506(PtB):1051-1055.
|
[73] |
Klein BEK, Howard KP, Gangnon RE, et al. Long-term Use of Aspirin and Age-Related Macular Degeneration[J]. JAMA, 2012, 308(23):2469-2478.
|
[74] |
Kam WR, Sullivan DA. Neurotransmitter Influence on Human Meibomian Gland Epithelial Cells[J]. Invest Ophthalmol Vis Sci, 2011, 52(12):8543-8548.
|
[75] |
Ding J, Kam WR, Dieckow J, et al. The influence of 13-cis retinoic acid on human meibomian gland epithelial cells[J]. Invest Ophthalmol Vis Sci, 2013, 54(6):4341-4350.
|
[76] |
Ubels JL, Wertz JT, Ingersoll KE, et al. Down-regulation of androgen receptor expression and inhibition of lacrimal gland cell proliferation by retinoic acid[J]. Exp Eye Res, 2002, 75(5):561-571.
|
[77] |
Bozkurt B, Irkec MT, Atakan N, et al. Lacrimal function and ocular complications in patients treated with systemic isotretinoin[J]. Eur J Ophthalmol, 2002, 12(3):173-176.
|
[78] |
Baudouin C, Renard JP, Nordmann JP, et al. Prevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertension[J]. Eur J Ophthalmol, 2013, 23(1):47-54.
|
[79] |
Gomes JAP, Azar DT, Baudouin C, et al. TFOS DEWSⅡ iatrogenic report[J]. Ocul Surf, 2017, 15(3):511-538.
|
[80] |
Alzahrani Y, Colorado LH, Pritchard N, et al. Longitudinal changes in Langerhans cell density of the cornea and conjunctiva in contact lens-induced dry eye[J]. Clin Exp Optom, 2017, 100(1):33-40.
|
[81] |
Nichols JJ, Sinnott LT. Tear film, contact lens, and patient-related factors associated with contact lens-related dry eye[J]. Invest Ophthalmol Vis Sci, 2006, 47(4):1319-1328.
|
[82] |
Yeniad B, Beginoglu M, Bilgin LK. Lid-wiper epitheliopathy in contact lens users and patients with dry eye[J]. Eye Contact Lens, 2010, 36(3):140-143.
|
[83] |
Schulze MM, Srinivasan S, Hickson-Curran SB, et al. Comparisons between Age, Gender, Lens Type and Lid Wiper Epitheliopathy with Soft Contact Lens Comfort[J]. Invest Ophthalmol Vis Sci, 2015, 56(7):6069.
|
[84] |
Torricelli AAM, Bechara SJ, Wilson SE. Screening of Refractive Surgery Candidates for LASIK and PRK[J]. Cornea, 2014, 33(10):1051-1055.
|
[85] |
Denoyer A, Landman E, Trinh L, et al. Dry Eye Disease after Refractive Surgery Comparative Outcomes of Small Incision Lenticule Extraction versus LASIK[J]. Ophthalmology, 2015, 122(4):669-676.
|
[86] |
Konomi K, Chen LL, Tarko RS, et al. Preoperative characteristics and a potential mechanism of chronic dry eye after LASIK[J]. Invest Ophthalmol Vis Sci, 2008, 49(1):168-174.
|
[87] |
Kymionis GD, Tsiklis NS, Ginis H, et al. Dry eye after photorefractive keratectomy with adjuvant mitomycin C[J]. J Refract Surg, 2006, 22(5):511-513.
|
[88] |
Donnenfeld ED, Solomon K, Perry HD, et al. The effect of hinge position on corneal sensation and dry eye after LASIK[J]. Ophthalmology, 2003, 110(5):1023-1029.
|
[89] |
Feng YF, Yu JG, Wang DD, et al. The effect of hinge location on corneal sensation and dry eye after LASIK: a systematic review and meta-analysis[J]. Graefes Arch Clin Exp Ophthalmol, 2013, 251(1):357-366.
|
[90] |
Mian SI, Li AY, Dutta S, et al. Dry eyes and corneal sensation after laser in situ keratomileusis with femtosecond laser flap creation Effect of hinge position, hinge angle, and flap thickness[J]. J Cataract Refract Surg, 2009, 35(12):2092-2098.
|
[91] |
Oh T, Jung Y, Chang D, et al. Changes in the tear film and ocular surface after cataract surgery [J]. Jpn J Ophthalmol, 2012, 56(2):113-118.
|
[92] |
Lyne A. Corneal sensitivity after surgery[J]. Trans Ophthalmol Soc UK, 1982, 102(Pt2):302-305.
|
[93] |
Yu Y, Hua H, Wu M, et al. Evaluation of dry eye after femtosecond laser-assisted cataract surgery[J]. J Cataract Refract Surg, 2015, 41(12):2614-2623.
|
[94] |
Cho H, Wolf KJ, Wolf EJ. Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution[J]. Clin Ophthalmol, 2009, 3(1):199-210.
|
[95] |
Khanal S, Tomlinson A, Esakowitz L, et al. Changes in corneal sensitivity and tear physiology after phacoemulsification[J]. Ophthalmic Physiol Opt, 2008, 28(2):127-134.
|
[96] |
Milosevic S, Bachnick B, Karim K, et al. Identification of MHCⅡ-restricted minor histocompatibility antigens after HLA-identical stem-cell transplantation[J]. Transplantation, 2010, 90(9):1030-1035.
|
[97] |
Hirst LW, Jabs DA, Tutschka PJ, et al. The eye in bone marrow transplantation. I. Clinical study[J]. Arch Ophthalmol, 1983, 101(4):580-584.
|
[98] |
Dietrich-Ntoukas T, Cursiefen C, Westekemper H, et al. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD[J]. Cornea, 2012, 31(3):299-310.
|
[99] |
Maskin SL. Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction[J]. Cornea, 2010, 29(10):1145-1152.
|
[100] |
Greiner JV. A single LipiFlow(R) Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months[J]. Curr Eye Res, 2012, 37(4):272-278.
|
[101] |
Lallemand F, Daull P, Benita S, et al. Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb[J]. Journal of Drug Delivery, 2012, 2012(2):604204.
|
[102] |
Liu Y, Kam WR, Sullivan DA. Influence of Omega 3 and 6 Fatty Acids on Human Meibomian Gland Epithelial Cells[J]. Cornea, 2016, 35(8):1122-1126.
|
[103] |
Oh HJ, Li Z, Park SH, et al. Effect of hypotonic 0.18% sodium hyaluronate eyedrops on inflammation of the ocular surface in experimental dry eye[J]. J Ocul Pharmacol Ther, 2014, 30(7):533-542.
|
[104] |
Choi KE, Song JS, Kang B, et al. Immediate Effect of 3% Diquafosol Ophthalmic Solution on Tear MUC5AC Concentration and Corneal Wetting Ability in Normal and Experimental Keratoconjunctivitis Sicca Rat Models[J]. Curr Eye Res, 2017, 42(5):666-671.
|
[105] |
Celebi AR, Ulusoy C, Mirza GE. The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study[J]. Graefes Arch Clin Exp Ophthalmol, 2014, 252(4):619-626.
|
[106] |
Chen MJ, Gong L, Sun XH, et al. A Comparison of Cyclosporine 0.05% Ophthalmic Emulsion Versus Vehicle in Chinese Patients with Moderate to Severe Dry Eye Disease: An Eight-Week, Multicenter, Randomized, Double-Blind, Parallel-Group Trial[J]. J Ocul Pharmacol Ther, 2010, 26(4):361-366.
|
[107] |
Lin T, Gong L. Topical Fluorometholone Treatment for Ocular Dryness in Patients With Sjogren Syndrome A Randomized Clinical Trial in China[J]. Medicine, 2015, 94(7):e551.
|
[108] |
肖璇,杨安怀,邢怡桥,等. 舌下腺的游离移植治疗重症干眼症的应用解剖学研究[J]. 武汉大学学报(医学版), 2005, 26(2):259-261.
|
[109] |
Tseng S. Amniotic membrane transplantation[J]. Am Ophthalmol, 2006, 38(4):271-283.
|
[110] |
Jones L, Downie LE, Korb D, et al. TFOS DEWSⅡ Management and Therapy Report[J]. Ocul Surf, 2017, 15(3):575-628.
|
[111] |
Gorska-Ciebiada M, Saryusz-Wolska M, Borkowska A, et al. Plasma levels of thrombomodulin, plasminogen activator inhibitor-1 and fibrinogen in elderly, diabetic patients with depressive symptoms[J]. Aging Clinical & Experimental Research, 2015, 28(5):1-9.
|
[112] |
Clark JE, Goon DT. The roles of resistance training for treatment of obesity related health issues and for changing health status of the individual who is overfat or obese: A review[J]. Journal of Sports Medicine & Physical Fitness, 2015, 55(3):205-222.
|
[113] |
Verity PG, Lagdon C. Relationships between lorica volume, carbon, nitrogen, and ATP content of tintinnids In Narragansett Bay[J]. Journal of Plankton Research, 2015, 6(5):859-868.
|
[114] |
Baudouin C, Liang H, Hamard P, et al. The Ocular Surface of Glaucoma Patients Treated over the Long Term Expresses Inflammatory Markers Related to Both T-Helper 1 and T-Helper 2 Pathways[J]. Ophthalmology, 2008, 115(1):109-115.
|
[115] |
Chotikavanich S, Paiva CSD, Li DQ, et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome[J]. Invest Ophthalmol Vis Sci, 2009, 50(7):3203-3209.
|